Drugs / Bacillus Licheniformis
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT03978949 | Jun 2019 → Aug 2021 | diarrheal disease | Asan Medical Center | Unknown | Missed primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT02993419 | Dec 2016 → Sep 2017 | diarrheal disease | Jiangsu Famous Medical Technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacillus licheniformis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02993419 ↗ |
| Known as | B. licheniformis | “These findings suggest that B. licheniformis does not significantly prevent RIE.” PMID 39451742 ↗ Oct 2024 |